Cargando…

Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients

Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lingping, Cao, Xiangqi, Wang, Rui, Duan, Yichao, Yang, Ye, Hou, Junlong, Wang, Jing, Chen, Bin, Xue, Xianjun, Zhang, Bo, Ma, Hua, Sun, Chaofeng, Guo, Fengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790085/
https://www.ncbi.nlm.nih.gov/pubmed/35097001
http://dx.doi.org/10.3389/fcvm.2021.781157
_version_ 1784639914194763776
author Xu, Lingping
Cao, Xiangqi
Wang, Rui
Duan, Yichao
Yang, Ye
Hou, Junlong
Wang, Jing
Chen, Bin
Xue, Xianjun
Zhang, Bo
Ma, Hua
Sun, Chaofeng
Guo, Fengwei
author_facet Xu, Lingping
Cao, Xiangqi
Wang, Rui
Duan, Yichao
Yang, Ye
Hou, Junlong
Wang, Jing
Chen, Bin
Xue, Xianjun
Zhang, Bo
Ma, Hua
Sun, Chaofeng
Guo, Fengwei
author_sort Xu, Lingping
collection PubMed
description Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-potentiated HUTT. Methods: The medical history and direct drug-potentiated HUTT records of patients who complained of syncope or precursor syncope and who visited The Xianyang Central Hospital from January 2016 to December 2020 were retrospectively reviewed. Results: A total of 4,873 patients (age = 43.8 ± 17.6 years; male = 2,064 [42.4%]) were enrolled in our study. Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%) with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH). The study showed that prior to syncope or near-syncope symptoms, patients first presented an increase in heart rate (HR), followed by decreases in blood pressure (BP) and HR successively. Among the patients in the syncope group, the sensitivity of the HUTT was 65.9%, which was significantly higher than a sensitivity of 44.8% for patients in the non-syncope group (P < 0.01). The sensitivity of the HUTT was higher for females than males in both the syncope group (52.6% in males and 77.9% in females, P < 0.01) and the non-syncope group (36.5% in males and 50.6% in females, P < 0.01). Within the four age groups (<20, 21–40, 41–60, and >60 years old), the sensitivities were 74.7%, 67.7%, 45.6%, and 31.2%, respectively. And all gender, age and symptom (whether suffered from a syncope or not) significantly affected the positive responses of HUTT. There were two adverse events and no deaths during the HUTT in this study. Conclusion: The direct drug-potentiated HUTT is a safe and highly sensitive tool with which to diagnose VVS. Patients with precursor syncope symptoms without syncope should undergo a HUTT, especially young females presenting with weakness and sweating, which can decrease the probability of a misdiagnosis or a missed diagnosis.
format Online
Article
Text
id pubmed-8790085
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87900852022-01-27 Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients Xu, Lingping Cao, Xiangqi Wang, Rui Duan, Yichao Yang, Ye Hou, Junlong Wang, Jing Chen, Bin Xue, Xianjun Zhang, Bo Ma, Hua Sun, Chaofeng Guo, Fengwei Front Cardiovasc Med Cardiovascular Medicine Background: The head-up tilt test (HUTT) is a useful diagnostic tool in patients with suspected vasovagal syncope (VVS). Objectives: We aimed to investigate the direct drug-potentiated HUTT in patients with recurrent syncope or precursor syncope and to assess the diagnostic value of the direct drug-potentiated HUTT. Methods: The medical history and direct drug-potentiated HUTT records of patients who complained of syncope or precursor syncope and who visited The Xianyang Central Hospital from January 2016 to December 2020 were retrospectively reviewed. Results: A total of 4,873 patients (age = 43.8 ± 17.6 years; male = 2,064 [42.4%]) were enrolled in our study. Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%) with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH). The study showed that prior to syncope or near-syncope symptoms, patients first presented an increase in heart rate (HR), followed by decreases in blood pressure (BP) and HR successively. Among the patients in the syncope group, the sensitivity of the HUTT was 65.9%, which was significantly higher than a sensitivity of 44.8% for patients in the non-syncope group (P < 0.01). The sensitivity of the HUTT was higher for females than males in both the syncope group (52.6% in males and 77.9% in females, P < 0.01) and the non-syncope group (36.5% in males and 50.6% in females, P < 0.01). Within the four age groups (<20, 21–40, 41–60, and >60 years old), the sensitivities were 74.7%, 67.7%, 45.6%, and 31.2%, respectively. And all gender, age and symptom (whether suffered from a syncope or not) significantly affected the positive responses of HUTT. There were two adverse events and no deaths during the HUTT in this study. Conclusion: The direct drug-potentiated HUTT is a safe and highly sensitive tool with which to diagnose VVS. Patients with precursor syncope symptoms without syncope should undergo a HUTT, especially young females presenting with weakness and sweating, which can decrease the probability of a misdiagnosis or a missed diagnosis. Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8790085/ /pubmed/35097001 http://dx.doi.org/10.3389/fcvm.2021.781157 Text en Copyright © 2022 Xu, Cao, Wang, Duan, Yang, Hou, Wang, Chen, Xue, Zhang, Ma, Sun and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Xu, Lingping
Cao, Xiangqi
Wang, Rui
Duan, Yichao
Yang, Ye
Hou, Junlong
Wang, Jing
Chen, Bin
Xue, Xianjun
Zhang, Bo
Ma, Hua
Sun, Chaofeng
Guo, Fengwei
Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title_full Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title_fullStr Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title_full_unstemmed Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title_short Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients
title_sort clinical features of patients undergoing the head-up tilt test and its safety and efficacy in diagnosing vasovagal syncope in 4,873 patients
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790085/
https://www.ncbi.nlm.nih.gov/pubmed/35097001
http://dx.doi.org/10.3389/fcvm.2021.781157
work_keys_str_mv AT xulingping clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT caoxiangqi clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT wangrui clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT duanyichao clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT yangye clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT houjunlong clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT wangjing clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT chenbin clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT xuexianjun clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT zhangbo clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT mahua clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT sunchaofeng clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients
AT guofengwei clinicalfeaturesofpatientsundergoingtheheaduptilttestanditssafetyandefficacyindiagnosingvasovagalsyncopein4873patients